The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Sat., Aug. 17, 11:56 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #94. Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) TotipotentRX Corporation

Acquirer: Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) (NASDAQ:KOOL)
Acquiree: TotipotentRX Corporation
Details: Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) ("Company") (Nasdaq:KOOL) today announced that it consummated the merger with TotipotentRX Corporation ("TotipotentRX") for approximately 12,490,800 shares of the Company's common stock, as contemplated by the previously announced Agreement and Plan of Reorganization (the "Merger Agreement").

Cesca Therapeutics is a regenerative medicine company engaged in developing, commercializing and marketing a range of automated technologies for cell-based therapeutics. Through its subsidary, ThermoGenesis Corp., Co. is developing the X-Series™ of devices and reagent kits as part of the CAR-TXpress™ platform.The initial X-Series™ products are for research use and/or non-commercial manufacturing of cell-based products for clinical research. Co. is also developing commercial manufacturing devices and reagent kits for cGMP manufacturing of CAR-T for drug developers. Co.'s X-Series™ Products includes X-LAB™ for cell isolation and X-BACS™ for cell purification.

Open the KOOL Page at The Online Investor »

Company Name: 
Cesca Therapeutics Inc
Website: 
www.cescatherapeutics.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding KOOL: 
2
Total Market Value Held by ETFs: 
$17407
Total Market Capitalization: 
$7.00M
% of Market Cap. Held by ETFs: 
0.25%
 

Open the KOOL Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
89th percentile
(ranked higher than approx. 89% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 94 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.